The Fertility Services Market Valued at USD 38.7 billion in 2023, projected to grow from USD 43.0 billion in 2024 to USD 83.86 billion by 2032, exhibiting a CAGR of 11.10% during the forecast period (2024 - 2032). Increased alcohol and drug use, higher stress levels, frequent smoking, obesity, and environmental factors are the key market drivers enhancing the market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The fertility market is being driven by a number of factors, including the increasing accessibility and availability of healthcare facilities, the rising success rates of in vitro fertilization (IVF) using ICSI in cases of poor sperm morphology, poor sperm motility, and low sperm count in men, and the increasing spending on healthcare and research.
Market growth is expected to be spurred by the rising prevalence of infertility-causing medical illnesses such as polycystic ovary syndrome (PCOS), endometrial tuberculosis, and sexually transmitted diseases (STDs). Increasing public knowledge and easier access to better healthcare facilities have also contributed to a rise in demand for these services in both developed and emerging nations. Therefore, the rise in infertility-related medical conditions has boosted the global Fertility Services market CAGR in recent years.
There are a number of factors contributing to the growth of the Fertility Services market revenue, including rising disposable incomes, flexible coverage options provided by health insurance providers, and increased advertising and promotion of reproductive services via television and internet portals.
Oma Fertility, a full-service fertility clinic that utilizes artificial intelligence (AI) and robots (robotics) in the laboratory while emphasizing human-centered care (HCC) in the clinic, announced the opening of three new clinics in May 2023 in the cities of Atlanta, New York, and St. Louis. These clinics, staffed by leading fertility experts, use cutting-edge technology to provide more people with access to quality fertility care, helping to combat the nation's rising infertility rates and satisfying the growing demand for comprehensive, reasonably priced medical options. Embryologists can use Oma Sperm InSight to select the best sperm for fertilization. Embryologists may examine twenty to thirty times as many sperm cells using an AI-driven microscope as they could with a conventional one, and then choose the best of the bunch.
January 2024- A network of infertility treatment hospitals, Indira IVF, on January 16th disclosed its international foray with the opening of its hospital in Kathmandu, Nepal. As per the press statement, this implies the company's first move beyond the Indian borders, putting in motion its next phase of growth with support from global private equity company EQT, which arrived as Indira IVF's majority owner in July 2023. Indira IVF is looking to take its proficiency to Southeast Asian, European, Middle Eastern, and African nations. As per the World HealthOrganisation (WHO), a predicted one out of every six people globally face challenges in creating at certain point in their lives, making infertility an extensive concern influencing millions. Fertility problems prevail in both developing and developed nations, where high costs, limited availability, and societal stigmatization of solutions contribute to the challenges. The complications of infertility, skilled by both women and men, add to its multifaceted nature. The global demand for fertility care extends over varied regions and demographics, highlighting the imperative for comprehensive solutions. India has been a center for medical tourism, with a rank of 10 in the Medical Tourism Index (MTI) for 2020-21 among the 46 destinations in the world. State-of-the-art facilities, financial viability, accreditation of hospitals, quick appointments, and presumed healthcare professionals have propelled this. Progressively, more patients have begun to visit the nation for sexual, reproductive, and fertility care. The company claimed that at Indira IVF's hospitals in India, nearly 400+ patients from Nepal, Bangladesh, and Sri Lanka have stayed the nation for their infertility treatment.
Numerous social and environmental factors, such as alterations in lifestyle, such as obesity, stress or depression, and heavy alcohol use, cause an increase in infertility rates, which in turn leads to a large need for Fertility Services . For instance, according to NPR, a non-profit media outlet located in the US, there were 4% fewer kids born in the country in 2020 than there were in 2019. Preliminary data revealed that at 55.8 births per 1,000 women aged 15 to 44, the total fertility rate fell to another another record low. The demand for fertility services will therefore increase as infertility rates rise.
The market for reproductive services is predicted to increase slowly due to the high cost of those procedures. The price of in-vitro fertilization (IVF) varies from patient to patient and is mostly dependent on the results of the infertility workup. For instance, an in-vitro fertilization (IVF) cycle costs $12,000 on average. One IVF cycle can cost between $10,000 and $15,000, not including the cost of medicines, which can range from as little as $1,500 to as much as $3,000 per cycle. Modern diagnostic procedures and different treatment modalities including hysteroscopy, IUI, and laparoscopy are utilized to facilitate and aid infertility treatment cost, which is contributing to the ongoing increase in the cost of IVF. Therefore, a significant obstacle to the growth of the market for fertility services is going to be the high cost of fertility therapy.
Additionally, it is anticipated that the increased frequency of different medical conditions, including endometrial tuberculosis, polycystic ovarian syndrome (PCOS), and sexually transmitted diseases (STDs) that can lead to infertility, will fuel the market's expansion. The usage of these services has also expanded in both developed and developing economies due to rising public awareness and more accessibility to better healthcare facilities. Therefore, such medical condition related to the infertility has enhanced the Fertility Services market CAGR across the globe in the recent years.
However, Additionally, rising disposable incomes, flexible coverage options provided by health insurance providers, and increased advertising and promotion of reproductive services on television and internet portals are all contributing to the market's expansion is another factor driving the growth of the Fertility Services market revenue.
The fertility services market segmentation, based on underlying cause, includes male infertility, and female infertility. The male Infertility segment held the majority share in 2021 contribution to around ~55% in respect to the fertility services market revenue. The market for male infertility is anticipated to be driven in the next years by rising infertility rates around the world and the introduction of assisted reproductive technologies (ARTs). Males with issues including low sperm count, aberrant sperm quality, and poor motility can find relief with ARTs, which span a broad spectrum of Fertility Services . In addition, ARTs have a higher success rate than medicines. Due to developments in assisted reproductive technology, the market for male infertility is anticipated to rise significantly in the coming years.
The fertility services market data has been bifurcated by Treatment Type into ART and infertility drugs. The ART segment dominated the market in 2021 and is projected to be the faster-growing segment during the forecast period, 2024-2032. During the projected period, factors including increased infertility rates, increasing ART success rates, and rising disposable income in developing nations are anticipated to propel industry expansion. World Health Organization Statistics 2020 estimates that 186 million people worldwide struggle with infertility-related issues. Numerous variables, including sexually transmitted infections (STIs), an increase in cigarette smoking, cases of obesity, endometriosis, polycystic ovary syndrome (PCOS), primary ovarian insufficiency (POC), and others, might be blamed for the rising prevalence of infertility.
July 2021: IVFTECH ApS (IVFtech) and its affiliated company, K4 Technology ApS, were purchased by Hamilton Throne Ltd., a global provider of ART research. With the help of its affiliated company, K4, IVFtech is committed to offering laminar flow workstations and large-capacity incubators for ART. The acquisition cost 8 million USD.
Figure 2: Fertility services market, by Treatment Type, 2023 & 2032 (USD Million)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
NewsMultiple factors, including people delaying having children and living unhealthy lifestyles, are driving up the need for fertility treatments in India in March 2023. After several years of development, Santaan opened its first fertility clinic and research center in Odisha. After establishing a strong foothold in Berhampur and Bhubaneshwar, Odisha, Santaan is expanding to new locations in Bangalore, Karnataka, and Ambur, Tamil Nadu. Santaan has created an IoT-based, AI-enabled quality monitoring solution for use in IVF labs and other biological monitoring settings. This allows the doctors to keep an eye on things from afar, improving quality control and patient outcomes. IVF is currently seen as a pricey treatment that is not suited to the Indian masses. In addition to their research and academy, they have set up a fully functional training center for embryologists.
The world's leading fertility clinic and IVF laboratory, CCRM Fertility, announced in July 2023 that it would be opening a new facility in Miami, Florida. Fertility testing, fertility preservation, intrauterine insemination, in vitro fertilization, preimplantation genetic testing, LGBTQ+ family building, and third-party reproduction are all offered at CCRM Fertility of Miami.
By Region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. Europe Fertility Services market accounted for USD 12.6871 billion in 2021 and is expected to exhibit a significant CAGR growth during the study period. The large percentage is ascribed to an increase in the infertility rate, greater knowledge of Fertility Services, developments in technology, and encouraging government programs. For instance, the European Union has the highest rate of infertility in the world—approximately 25 million people—according to the European Society of Human Reproduction and Embryology. During the projection period, North America is anticipated to experience significant expansion. The growth is linked to the success that people experiencing the treatment are experiencing. Further, the Germany Fertility Services market held the largest market share, and the UK Fertility Services market was the fastest growing market in the European region
Further, the major countries studied in the market report are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: Fertility services market SHARE BY REGION 2023 (%)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
North America Fertility Services market accounts for the second-largest market share. owing to the launch and rapid uptake of multiple infertility medicines. Increasing research activities in the region in the field of infertility are projected to open new opportunities in the region. Further, the US Fertility Services market held the largest market share, and the Canada Fertility Services market was the fastest growing market in the European region
The Asia-Pacific Fertility Services Market is expected to grow at the fastest CAGR from 2024 - 2032. The growth of the region is attributed to the presence of key players in the market and strategic initiatives undertaken by them to develop and commercialize new infertility medicinal products to treat patients. Moreover, China Fertility Services market held the largest market share, and the India Fertility Services market was the fastest growing market in the Asia-Pacific region
Fertility Services Key Market Players & Competitive Insights
The Fertility Services market will expand much more as a result of major industry players high R&D expenditures to expand their product ranges. In addition, market participants are launching key developments, entering into contracts, acquiring companies, increasing investments, and working with other organizations, among other significant market changes, in an effort to expand their global footprint. In order to grow and survive in a market that is becoming more competitive and growing, competitors in the Fertility Services industry must offer products that are affordable.
Manufacturing locally in order to cut operational costs is one of the main business tactics used by producers in the global Fertility Services industry to benefit customers and grow the market sector.In recent years, Fertility Services industry has provided medicine with some of the most significant benefits. The Fertility Services market major player such as CooperCompanies,Mankind and others are working to expand the market demand by investing in research and development activities.
CooperCompanies is a global, consumer-centric medical device company that supports how people want to live, at every stage of life. In December 2021, ooperCompanies, a US-based company specializing in women’s healthcare solutions, acquired Generate Life Sciences for $1.6 billion. Through this acquisition, CooperSurgical offers an even stronger selection of fertility centres and OB/GYNs. Generate Life Sciences is a US-based provider of donor eggs and sperm for Fertility Services , fertility cryopreservation services and newborn stem cell storage.
Also, Mankind Pharma has a vast and gigantic network of partners and distributors to make the medicines available at every nook and corner of the country. Product categories start right from Antibiotics, Antifungals, NSAIDs, Gastrointestinal, and Anthelmintic to Cardiovascular, Dermal, Neuro Psychiatry, Erectile Dysfunction, and several others. In June 2022, Mankind Pharma developed and launched a generic version of Dydrogestrone tablets for the treatment of patients’ pregnancy-related complications in India. This drug was an equivalent version of Abbott Duphaston tablets. This launch was expected to drive Fertility Services market.
Key Companies in the Fertility Services market includes
Fertility Services Industry Developments
October 2022:Maven Clinic, a US-based company specializing in telemedicine-based virtual clinic for women's and family health, collaborated with Indira IVF. The collaboration aimed at providing access to Maven members in India to Indira IVF's high-quality clinical care, other perks, and the best virtual family-building care available through the Maven platform. Indira IVF is an India-based infertility speciality clinic chain.
November 2020:Ferring B.V. and Igenomix entered into a four-year research collaboration to develop novel therapeutic products for the treatment of patients with pregnancy-related conditions.
| Report Attribute/Metric | Details |
| Market Size 2023 | USD 38.7 billion |
| Market Size 2024 | USD 42.99 billion |
| Market Size 2030 | USD 83.86 billion |
| Compound Annual Growth Rate (CAGR) | 11.1% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2020 & 2021 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Underlying Cause, Treatment type and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and Rest of the World |
| Countries Covered | The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Merck KGaA, Cook Medical, Irvine Scientific Company Inc., Copper Surgical, Kitazato Cooperation, Vitrolife, Ferring B. V, Invo Bioscience, Monash IVF Group, and Care Fertility |
| Key Market Opportunities | Developing advanced devices |
| Key Market Dynamics | Rise in obesity, along with the consumption of alcohol/cigarettes |
Fertility Services Market Highlights:
Frequently Asked Questions (FAQ) :
The fertility services market size was valued at USD 38.7 Billion in 2023.
The global market is projected to grow at a CAGR of 11.1% during the forecast period, 2024-2032.
North America had the largest share in the global market
The key players in the market are Merck KGaA, Cook Medical, Irvine Scientific Company Inc., Copper Surgical, Kitazato Cooperation).
The male Infertility category dominated the market in 2021.
The ART had the largest share in the global market.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
